Thursday, March 31, 2016

CGP3466B compound may effectively treat depression

›
We know that,  Omigapil   ( TCH346   or   CGP3466 ) is a   drug   that was developed by   Novartis   and tested in   clinical trials...
Wednesday, March 30, 2016

Mylan announces launch of Linezolid Tablets, 600 mg in U.S.

›
In continuation of my update on Linezolid Mylan N.V.  announced the U.S. launch of Linezolid Tablets, 600 mg, which is the gener...

UTA chemists design efficient water-based system for synthesis of organic compounds

›
Chemists at The University of Texas at Arlington have devised a safer, more environmentally friendly, less expensive and more efficient wate...
Tuesday, March 29, 2016

New oral breast cancer drug has potential to combat other types of cancer

›
In continuation of my update on  Palbociclib Palbociclib, a new oral drug whose efficacy in combating breast cancer has been demon...
Monday, March 28, 2016

Potent parasite-killing mechanism of anti-malarial drug uncovered: New understanding of how artemisinin works could facilitate development of new drugs and therapeutic strategies against malaria -- ScienceDaily

›
In continuation of my update on artemisinin A team of researchers has uncovered the mystery behind the potent parasite-killing effec...
Friday, March 25, 2016

New Breast Cancer Drug May Be Effective Against Other Types of Cancer, Abramson Cancer Center Experts Find

›
In continuation of my update on  Palbociclib , Palbociclib, a new oral drug whose efficacy in combating breast cancer has been ...
Thursday, March 24, 2016

Afatinib a better choice for EGFR-mutated lung cancer in first-line treatment

›
In continuation of my update on Afatinib Patients with EGFR-activating mutations in advanced lung cancer seem to benefit more fr...
Wednesday, March 23, 2016

Osteoarthritis: pivotal Phase III trial successfully meets primary efficacy endpoint - Medical News Today

›
Celecoxib/amlodipine besylate (KIT-302)    itov Pharmaceuticals, an innovative biopharmaceutical company focused on late-stage drug ...
Monday, March 21, 2016

FDA approves non-alcoholic Docetaxel Injection

›
In continuation of my update on  Docetaxel Teikoku Pharma USA, Inc. ("Teikoku" or "the Company") announced today...
Friday, March 18, 2016

Teva Pharmaceuticals and Eagle Pharmaceuticals Announce FDA Approval of Bendeka (bendamustine hydrochloride) Injection

›
Teva Pharmaceutical Industries Ltd. (NYSE:TEVA) and Eagle Pharmaceuticals, Inc. (Nasdaq:EGRX) today announce that the U.S. Food and Drug...
2 comments:
Thursday, March 17, 2016

FDA Approves Bridion (sugammadex) to Reverse Effects of Neuromuscular Blocking Drugs

›
"Bridion provides a new treatment option that may help patients recover sooner from medications used for intubation or ventilation du...
Wednesday, March 16, 2016

FDA Approves Uptravi (selexipag) for Pulmonary Arterial Hypertension

›
On December 21, the U.S. Food and Drug Administration approved Uptravi (selexipag) tablets to treat adults with pulmonary arterial hyperte...
Tuesday, March 15, 2016

FDA Approves Alecensa (alectinib) for ALK-Positive Non-Small Cell Lung Cancer

›
The U.S. Food and Drug Administration today approved Alecensa (alectinib) to treat people with advanced (metastatic) ALK-positive non-...
Monday, March 14, 2016

FDA Approves Zurampic (lesinurad) to Treat High Blood Uric Acid Levels Associated with Gout

›
The U.S. Food and Drug Administration today approved Zurampic (lesinurad) to treat high levels of uric acid in the blood (hyperurice...
Friday, March 11, 2016

New type of hydrogen bond discovered

›
An entirely new class of hydrogen bond that forms between a boron–hydrogen group and the aromatic, π-electron system of a benzene rin...